Robert Cobuzzi

Dr. Cobuzzi has served as President, Chief Executive Officer, and Board Member since September 2020 and as a director since January 2020. He has over 25 years of cross-functional leadership experience in the pharmaceutical and biotechnology industries across the areas of Corporate Development, Research & Development, and Operations.

From 2005 until 2018 Dr. Cobuzzi held a variety of senior roles in Corporate Development, R&D, and Operations at Endo International Plc, including most recently as President, Endo Ventures Limited in Dublin, Ireland from 2015 until 2018. Prior to Endo, he was with Adolor Corporation from 2001 until 2005. He began his career in 1995 at Astra Merck in clinical operations before joining Centocor (a subsidiary of Johnson & Johnson) in Worldwide Regulatory Affairs from 1999 to 2001. Dr. Cobuzzi currently serves as a Venture Partner for Sunstone Life Science Ventures and also is Chairman of Sunstone’s Business Development Board. He was previously a member of the U.S. Department of Commerce’s Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health/Science Products, and Services, and served as a board member for two development-stage medical device companies. Dr. Cobuzzi holds an AB in Biochemistry and Art History from Colby College and a Ph.D. in Molecular and Cellular Biochemistry from Loyola University Chicago. He was a post-doctoral fellow in the Department of Experimental Therapeutics at the Roswell Park Cancer Institute in Buffalo, N.Y.